Good article today in the Globe and Mail on how Canada has been wasteland for Biotech funding and only retail investors invest in Cdn biotechs. Link for the article below, but unfortunately, I think you need to be a subscriber to read. No mention of RVX in the article nor in a Q&A on Cdn biotechs with Brian Bloom of Bloom Burton 

https://www.theglobeandmail.com/business/article-biotech-blind-spot-how-canadas-big-investors-missed-the-boom/